Empagliform 12.5/1000 mg 30 tablets
Hikma Pharmaceuticals
Hikma Pharmaceuticals
Overview
Empagliform 12.5/1000 mg is a fixed-dose combination tablet containing empagliflozin and metformin, used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes.
Key Benefits
- Combines two complementary mechanisms of action in a single tablet
- Empagliflozin helps lower blood glucose and has been associated with reduced cardiovascular death risk in adults with type 2 diabetes and established cardiovascular disease
- Metformin supports glycemic control as an established first-line therapy
- Simplifies dosing by combining two medicines in one tablet
- Intended as an adjunct to diet and exercise, not a replacement for lifestyle management
How to Use
Take by mouth exactly as prescribed by your doctor, typically with meals to reduce stomach upset. Do not change the dose without medical advice.
Active Ingredients
Metformin hydrochloride 1000 mg, Empagliflozin 12.5 mg.
Precautions
This is a prescription medicine for adults with type 2 diabetes. Inform your pharmacist of any kidney or liver conditions, other medications, or planned surgery before use.
Storage
Store at room temperature, away from moisture and direct sunlight, out of reach of children.